Maravai Lifesciences Holdings Stock Buy Hold or Sell Recommendation
| MRVI Stock | USD 5.22 0.26 5.24% |
Given the investment horizon of 90 days and your typical level of risk aversion, our recommendation regarding Maravai Lifesciences Holdings is 'Strong Sell'. The recommendation algorithm takes into account all of Maravai Lifesciences' available fundamental, technical, and predictive indicators you will find on this site.
Check out Maravai Lifesciences Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as Maravai and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Maravai Lifesciences Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
Maravai |
Execute Maravai Lifesciences Buy or Sell Advice
The Maravai recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Maravai Lifesciences Holdings. Macroaxis does not own or have any residual interests in Maravai Lifesciences Holdings or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Maravai Lifesciences' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Relatively risky | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Almost mirrors the market | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Strong | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Maravai Lifesciences Trading Alerts and Improvement Suggestions
| Maravai Lifesciences generated a negative expected return over the last 90 days | |
| Maravai Lifesciences has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 288.94 M. Net Loss for the year was (119.03 M) with profit before overhead, payroll, taxes, and interest of 714.04 M. | |
| Maravai Lifesciences has a strong financial position based on the latest SEC filings | |
| Over 99.0% of the company shares are owned by institutional investors | |
| Latest headline from gurufocus.com: Disposition of 4363 shares by Rebecca Buzzeo of Maravai Lifesciences at 4.42 subject to Rule 16b-3 |
Maravai Lifesciences Returns Distribution Density
The distribution of Maravai Lifesciences' historical returns is an attempt to chart the uncertainty of Maravai Lifesciences' future price movements. The chart of the probability distribution of Maravai Lifesciences daily returns describes the distribution of returns around its average expected value. We use Maravai Lifesciences Holdings price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Maravai Lifesciences returns is essential to provide solid investment advice for Maravai Lifesciences.
| Mean Return | -0.59 | Value At Risk | -7.29 | Potential Upside | 5.62 | Standard Deviation | 6.01 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Maravai Lifesciences historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Maravai Stock Institutional Investors
| Shares | Ameriprise Financial Inc | 2024-06-30 | 3 M | Jennison Associates Llc | 2024-09-30 | 3 M | State Street Corp | 2024-06-30 | 2.8 M | Geode Capital Management, Llc | 2024-09-30 | 2.8 M | Point72 (difc) Ltd | 2024-09-30 | 2.7 M | Fmr Inc | 2024-09-30 | 2.5 M | Glenmede Trust Co Na | 2024-09-30 | 2.2 M | Alyeska Investment Group, L.p. | 2024-09-30 | 2.2 M | Bamco Inc | 2024-09-30 | 2.1 M | Gtcr Llc | 2024-09-30 | 20.2 M | 12 West Capital Management Lp | 2024-09-30 | 14 M |
Maravai Lifesciences Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | 106K | (19.1M) | (21.6M) | 9.5M | 649K | 681.5K | |
| Investments | (17.1M) | 6.1M | 105.7M | (267.6M) | (127.9M) | (121.5M) | |
| Change In Cash | 2.8M | 211.5M | 315.1M | 80.9M | (57.2M) | (54.3M) | |
| Net Borrowings | (2.6M) | 196.9M | (6M) | (5.4M) | (4.9M) | (4.7M) | |
| Free Cash Flow | 7.0M | 126.8M | 353.7M | 518.9M | 60.7M | 57.6M | |
| Depreciation | 24.1M | 25.8M | 24.8M | 38.1M | 48.8M | 33.7M | |
| Other Non Cash Items | 2.4M | (7.5M) | (6.2M) | (8.7M) | (690.9M) | (656.4M) | |
| Capital Expenditures | 17.1M | 25.4M | 14.9M | 17.1M | 65.6M | 68.8M | |
| Net Income | (5.2M) | 78.8M | 469.3M | 490.7M | (119.0M) | (113.1M) | |
| End Period Cash Flow | 24.7M | 236.2M | 551.3M | 632.1M | 575.0M | 374.2M | |
| Change To Netincome | 477K | (340K) | 45.8M | 320.0M | 368.0M | 386.4M |
Maravai Lifesciences Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Maravai Lifesciences or Life Sciences Tools & Services sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Maravai Lifesciences' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Maravai stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.73 | |
β | Beta against Dow Jones | 1.07 | |
σ | Overall volatility | 6.08 | |
Ir | Information ratio | -0.12 |
Maravai Lifesciences Volatility Alert
Maravai Lifesciences Holdings is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Maravai Lifesciences' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Maravai Lifesciences' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Maravai Lifesciences Fundamentals Vs Peers
Comparing Maravai Lifesciences' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Maravai Lifesciences' direct or indirect competition across all of the common fundamentals between Maravai Lifesciences and the related equities. This way, we can detect undervalued stocks with similar characteristics as Maravai Lifesciences or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Maravai Lifesciences' fundamental indicators could also be used in its relative valuation, which is a method of valuing Maravai Lifesciences by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Maravai Lifesciences to competition |
| Fundamentals | Maravai Lifesciences | Peer Average |
| Return On Equity | -0.43 | -0.31 |
| Return On Asset | -0.0161 | -0.14 |
| Profit Margin | (0.81) % | (1.27) % |
| Operating Margin | (0.23) % | (5.51) % |
| Current Valuation | 723.34 M | 16.62 B |
| Shares Outstanding | 141.84 M | 571.82 M |
| Shares Owned By Insiders | 1.30 % | 10.09 % |
| Shares Owned By Institutions | 98.70 % | 39.21 % |
| Number Of Shares Shorted | 8.22 M | 4.71 M |
| Price To Earning | 7.79 X | 28.72 X |
| Price To Book | 2.15 X | 9.51 X |
| Price To Sales | 4.76 X | 11.42 X |
| Revenue | 288.94 M | 9.43 B |
| Gross Profit | 714.04 M | 27.38 B |
| EBITDA | 712.41 M | 3.9 B |
| Net Income | (119.03 M) | 570.98 M |
| Cash And Equivalents | 617.45 M | 2.7 B |
| Cash Per Share | 4.69 X | 5.01 X |
| Total Debt | 610.97 M | 5.32 B |
| Debt To Equity | 0.69 % | 48.70 % |
| Current Ratio | 7.22 X | 2.16 X |
| Book Value Per Share | 2.44 X | 1.93 K |
| Cash Flow From Operations | 126.22 M | 971.22 M |
| Short Ratio | 6.63 X | 4.00 X |
| Earnings Per Share | (1.67) X | 3.12 X |
| Price To Earnings To Growth | (0.22) X | 4.89 X |
| Target Price | 9.73 | |
| Number Of Employees | 580 | 18.84 K |
| Beta | 0.024 | -0.15 |
| Market Capitalization | 1.32 B | 19.03 B |
| Total Asset | 1.49 B | 29.47 B |
| Retained Earnings | 285.74 M | 9.33 B |
| Working Capital | 612.44 M | 1.48 B |
Note: Disposition of 8409946 shares by Gtcr Investment Xi Llc of Maravai Lifesciences subject to Rule 16b-3 [view details]
Maravai Lifesciences Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Maravai . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Maravai Lifesciences Buy or Sell Advice
When is the right time to buy or sell Maravai Lifesciences Holdings? Buying financial instruments such as Maravai Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Maravai Lifesciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Currency Funds Thematic Idea Now
Currency Funds
Funds or Etfs investing in a single currency or combination of currencies from different countries in order to replicate respective foreign exchange markets. The Currency Funds theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Currency Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Maravai Lifesciences Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Maravai Lifesciences. If investors know Maravai will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Maravai Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.33) | Earnings Share (1.67) | Revenue Per Share 2.044 | Quarterly Revenue Growth (0.03) | Return On Assets (0.02) |
The market value of Maravai Lifesciences is measured differently than its book value, which is the value of Maravai that is recorded on the company's balance sheet. Investors also form their own opinion of Maravai Lifesciences' value that differs from its market value or its book value, called intrinsic value, which is Maravai Lifesciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Maravai Lifesciences' market value can be influenced by many factors that don't directly affect Maravai Lifesciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Maravai Lifesciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Maravai Lifesciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Maravai Lifesciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.